CABENVUA and VOCABRIA approved for HIV infection
WEBJan 27, 2021 · CABENUVA, a 2-drug co-packaged product of cabotegravir, a human immunodeficiency virus type-1 (HIV-1) integrase strand transfer inhibitor (INSTI), and rilpivirine, an HIV-1 non-nucleoside reverse...
FDA Approves New HIV Drug for Adults with Limited Treatment …
WEBJan 4, 2023 · Sunlenca is the first of a new class of drugs called capsid inhibitors to be FDA-approved for treating HIV-1. Sunlenca works by blocking the HIV-1 virus’ protein shell (the capsid), thereby interfering with multiple essential steps of the viral lifecycle.
FDA-Approved HIV Medicines | NIH - HIVinfo
WEBJul 31, 2024 · The following table lists HIV medicines recommended for the treatment of HIV infection in the United States, based on the U.S. Department of Health and Human Services (HHS) HIV and AIDS medical practice guidelines. All of these drugs are approved by the U.S. Food and Drug Administration (FDA).
New HIV drug can only offer hope of ending AIDS if all have …
WEBGENEVA, 10 July 2024— UNAIDS has welcomed the release of Gilead Sciences’ trial results on the injectable long-acting HIV medicine Lenacapavir for HIV prevention. The result “provides hope of accelerating efforts to end AIDS”, UNAIDS says, “but only if Gilead ensures that all people who need it can have access to this game-changing ...
Twice-yearly shot proves successful at preventing HIV infection ... - CNN
WEBJul 24, 2024 · The twice-yearly injection of the drug lenacapavir can provide total protection against HIV infections, demonstrating 100% efficacy in Phase 3 trial data released by drugmaker Gilead and...
FDA Approves First Extended-Release, Injectable Drug Regimen ... - HIV…
WEBJan 22, 2021 · [Yesterday] the U.S. Food and Drug Administration approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral ...
FDA Approves First Injectable Treatment for HIV Pre-Exposure …
WEBToday, the U.S. Food and Drug Administration approved Apretude (cabotegravir extended-release injectable suspension) for use in at-risk adults and adolescents weighing at least 35 kilograms (77...
FDA Approves First Extended-Release, Injectable Drug Regimen …
WEBJan 21, 2021 · The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type...
A two-dose schedule could make HIV vaccines more effective
WEB2 days ago · In a new study, the researchers have now found that they can achieve a similar immune response with just two doses, given one week apart. The first dose, which is much smaller, prepares the immune system …
At #UNGA79 UNAIDS will call on global leaders to roll-out new ...
WEB2 days ago · Lenacapavir, a new injectable medicine administered once every six months has shown in trials to be nearly 100% effective in preventing HIV with trials having been halted early due to the effectiveness of the new medicine.